Inspire Medical Systems Inc (INSP)
Profitability ratios
Return on sales
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 84.77% | 84.83% | 84.65% | 84.54% | 84.10% | 83.74% | 83.91% | 84.14% | 84.72% | 85.99% | 86.49% | 86.53% | 86.11% | 86.01% | 85.90% | 85.91% | 86.15% | 85.18% | 84.34% | 83.37% |
| Operating profit margin | 1.79% | -2.03% | -5.45% | -6.45% | -8.75% | -10.21% | -10.97% | -11.72% | -14.18% | -13.95% | -15.45% | -17.23% | -22.61% | -26.03% | -41.76% | -49.39% | -61.71% | -71.28% | -49.13% | -42.53% |
| Pretax margin | 4.90% | 1.21% | -2.13% | -3.20% | -5.60% | -7.67% | -9.22% | -10.90% | -14.43% | -14.63% | -16.30% | -18.17% | -23.60% | -27.09% | -42.96% | -50.18% | -61.96% | -70.56% | -47.54% | -40.47% |
| Net profit margin | 4.37% | 0.85% | -2.38% | -3.39% | -5.75% | -7.82% | -9.37% | -11.05% | -14.57% | -14.70% | -16.34% | -18.18% | -23.64% | -27.18% | -43.05% | -50.27% | -62.09% | -70.61% | -47.59% | -40.52% |
Inspire Medical Systems Inc's profitability ratios display a consistent trend over the past years. The gross profit margin has remained relatively stable, ranging between 84% to 87%, indicating efficient cost management in generating revenue. However, the operating profit margin shows a decline, ranging from -2% to -17%, signifying challenges in controlling operating expenses.
The pretax margin and net profit margin also show a decreasing trend, ranging from 0.85% to 4.9% and -3.39% to 4.37%, respectively, indicating difficulties in generating profits after considering all expenses and taxes. The negative values in some periods reflect the challenges faced by the company in maintaining profitability.
Overall, the declining trend in operating, pretax, and net profit margins suggests that Inspire Medical Systems Inc faces profitability challenges that need to be addressed to improve its financial performance and sustainability.
Return on investment
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 1.70% | -1.96% | -5.25% | -5.95% | -7.80% | -8.67% | -8.92% | -8.43% | -9.30% | -14.27% | -13.88% | -13.50% | -16.17% | -16.60% | -20.28% | -19.99% | -21.50% | -21.08% | -25.68% | -19.25% |
| Return on assets (ROA) | 4.15% | 0.83% | -2.29% | -3.13% | -5.12% | -6.64% | -7.63% | -7.95% | -9.56% | -15.04% | -14.68% | -14.25% | -16.90% | -17.33% | -20.91% | -20.34% | -21.63% | -20.88% | -24.87% | -18.34% |
| Return on total capital | 1.94% | -1.41% | -4.39% | -4.52% | -6.53% | -8.17% | -8.99% | -9.31% | -10.14% | -17.55% | -16.91% | -16.27% | -18.80% | -18.58% | -22.16% | -21.61% | -22.31% | -21.11% | -25.71% | -18.91% |
| Return on equity (ROE) | 4.74% | 0.94% | -2.67% | -3.69% | -6.02% | -7.76% | -8.64% | -9.05% | -10.72% | -19.35% | -18.89% | -18.36% | -21.40% | -21.45% | -25.62% | -24.90% | -25.70% | -24.26% | -32.36% | -23.77% |
Inspire Medical Systems Inc's profitability ratios have exhibited varying trends over the past few quarters. The Operating Return on Assets (Operating ROA) was negative in some quarters, indicating the company's operating earnings generated from its assets were insufficient to cover operational expenses. However, it showed improvement in the latest quarter, reaching 1.70%.
Return on Assets (ROA) also experienced fluctuations, with negative values in most quarters, suggesting challenges in generating profits from its overall assets. Despite this, there was a slight improvement, with ROA rising to 4.15% in the most recent period.
Return on Total Capital displayed a similar trend, with negative values across most quarters, indicating inefficiencies in generating returns from the total invested capital. Like ROA, there was a slight improvement in the latest quarter to 1.94%.
Return on Equity (ROE) also fluctuated, with negative values in several quarters, signaling a struggle to generate returns for shareholders' equity. The latest period saw an increase to 4.74%, suggesting a better performance in generating profits relative to shareholder equity.
Overall, while there have been signs of improvement in profitability ratios in the most recent quarter, Inspire Medical Systems Inc still faces challenges in efficiently utilizing its assets and capital to generate profits for its shareholders. Continued monitoring and strategic adjustments may be necessary to improve overall profitability.